English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduNearly 1 in 8 men will be diagnosed with prostate cancer in their lifetime, which is about the same risk a woman has of developing breast cancer.1
While screening for prostate cancer often starts with a simple blood test known as the prostate-specific antigen (PSA) test, prostate cancer screening has been the source of some controversy in recent years, and as a result, men may not be aware of when to start screening. A recent report from the American Cancer Society detailed an alarming increase in rates of advanced prostate cancer among men, and the disease continues to disproportionally affect Black men, who are twice as likely to die from the disease than White men.2
This month, the American College of Surgeons (ACS) has partnered with the American Urological Association (AUA) to share vital information about the concerning rise in advanced cases of prostate cancer and how men can protect their health and make the most informed decisions about their healthcare.
For journalists: Journalists may email [email protected] to schedule interviews with expert physicians to discuss prostate cancer awareness.
On Monday, September 11 at 11 AM CT/12 PM ET, join Kara Watts, MD, an associate professor of urology at Montefiore Medical Center, and Kevin Koo, MD, MPH, an associate professor of urology at Mayo Clinic College of Medicine and Science, for a virtual news conference hosted by the ACS and AUA.
Dr. Watts and Dr. Koo will discuss and answer questions on the latest news on preventing and treating prostate cancer, the most commonly diagnosed cancer in men after skin cancer.
Media register to attend and/or receive transcript and video
Topics the panelists can address:
- Rise in advanced cases of prostate cancer and what men can do to protect their health
- Patient populations most at risk for prostate cancer, including Black men, who are twice as likely to die of prostate cancer than White men and have a 73% increased incidence of the disease compared with White men.2 Some research indicates that prostate cancer has the widest racial disparities of any cancer.3
- Prostate cancer screening guidelines and what to know about the prostate-specific antigen (PSA) test and other screening techniques
- Common misconceptions about prostate cancer screening and treatment
- How patients can effectively talk to their doctor about prostate cancer
- Latest advances in how prostate cancer is treated
For journalists and the public: The ACS and AUA have developed a comprehensive fact page to distill essential information on prostate cancer, as well as tips and advice from physicians on how best to communicate concerns about prostate cancer screening and treatment.
—-
- American Cancer Society, Key Statistics for Prostate Cancer: https://www.cancer.org/cancer/types/prostate-cancer/about/key-statistics.html
- Prostate Cancer Research Highlights, American Cancer Society: https://www.cancer.org/research/acs-research-highlights/prostate-cancer-research-highlights.html
- Chowdhury-Paulino IM, Ericsson C, Vince Jr R, Spratt DE, George DJ, Mucci LA. Racial disparities in prostate cancer among black men: epidemiology and outcomes. Prostate Cancer and Prostatic Diseases. 2022 Sep;25(3):397-402.
# # #
About the American College of Surgeons
The American College of Surgeons is a scientific and educational organization of surgeons that was founded in 1913 to raise the standards of surgical practice and improve the quality of care for all surgical patients. The College is dedicated to the ethical and competent practice of surgery. Its achievements have significantly influenced the course of scientific surgery in America and have established it as an important advocate for all surgical patients. The College has more than 88,000 members and is the largest organization of surgeons in the world. “FACS” designates a surgeon is a Fellow of the American College of Surgeons.
